13
C NMR spectrum (CDCl ): 18.27 (q, CH C-2), 19.08 (q, CH C-6), 27.67 (d, C-6), 30.03 (t, C-5), 37.80 (t, C-4),
3
3
3
40.61 (d, C-2), 41.61 (t, C-7), 62.49 (t, C-8), 214.38 (s, C-3).
3R,7-Dimethyloctan-1,6S-diol (8). A solution of 7 (23.5 mmol) prepared as before [8] in dry CH Cl (80 mL) was
2
2
treated dropwise (Ar, -15°C) with a toluene solution (12.5 mL, 73%) of diisobutylaluminium hydride (DIBAH) in dry CH Cl
2
2
(10 mL), stored (-15°C, 1 h; 20°C, 12 h), and treated successively with THF (11 mL) and H O (25 mL). The resulting solid
2
was filtered off with a sintered-glass filter. The organic layer was dried over MgSO , filtered, and evaporated to afford 8
4
20
-1
(3.33 g, 83%), R 0.10 (PE:ethylacetate = 7:3), [α]
-10.3° (c 2.43, CHCl ). IR spectrum (KBr, ν, cm ): 3200-3600, 1100,
3
f
D
1055 (OH).
PMR spectrum (CDCl , δ, ppm, J/Hz): 0.75-0.95 (9H, ddd, J = 6.7, CH C-3, CH C-7, H-8), 1.10-1.70 (9H, m,
3
3
3
H-2—H-7), 2.50 (2H, br.s, OH), 3.50-3.75 (2H, m, H-1).
13
C NMR spectrum (CDCl ): 16.99 and 18.81 (q, CH C-7, C-8), 19.74 (q, CH C-3), 29.54 (d, C-3), 31.20 (t, C-5),
3
3
3
32.77 (t, C-4), 33.37 (d, C-7), 39.58 (t, C-2), 60.13 (t, C-1), 76.67 (d, C-6).
2,6R-Dimethyl-8-hydroxyoctan-3-one(3),3,7-Dimethyl-6-oxooctyl Ester of 3,7-Dimethyl-6-oxooctanoic Acid (10),
and 3R,7-Dimethyl-6-oxooctanoic Acid (11).
a. A solution of8 (1.18 g, 6.8 mmol) and glacial AcOH(5 mL) at room temperature was treated dropwise with aqueous
NaClO (7.2 mL, 1 M) and then after 30 min with another portion (7.2 mL) of the same solution, stirred for 12 h until the
peroxide disappeared (iodine—starch test), diluted with ethylacetate (50 mL), washed successively with saturated solutions of
NaHCO and NaCl, dried over Na SO , filtered, and evaporated to produce a mixture (1.01 g) consisting according to GC of
3
2
4
3 (16%), 10 (61%), and 11 (23%), which was separated chromatographically over SiO (PE:ethylacetate = 7:3).
2
b. A solution of 8 (1.00 g, 6.0 mmol) in glacial AcOH (3 mL) at room temperature was treated dropwise over 1 h with
aqueous NaClO (6.0 mL, 1 M, 6.0 mmol), extracted with CH Cl (3 × 30 mL), washed successively with saturated solutions
2
2
of NaHCO and NaCl, dried over Na SO , filtered, and evaporated to produce 3 (0.86 g, 87%).
3
2
4
c. A suspension ofpyridinium chlorochromate (PCC, 5.02 g, 23.3 mmol) in dryCH Cl (8 mL) (Ar, 20°C) was treated
2
2
dropwise with 8 (1.30 g, 7.5 mmol) in dry CH Cl (5 mL), stored for 2 h, diluted with Et O (20 mL), and filtered through SiO
2
2
2
2
(20 g) on a sintered-glass filter. The filtrate was evaporated. The solid 3R,7-dimethyloctan-6-on-1-al (9, 1.25 g, R 0.50,
f
PE:ethylacetate = 7:3) was dissolved in dry CH Cl (10 mL), stirred (10°C), and treated with a previouslyprepared suspension
2
2
of NaBH(OAc) [prepared by adding a solution of glacial AcOH (6.20 g, 103.0 mmol) in CH Cl (10 mL) to a suspension of
3
2
2
NaBH (1.30 g, 34.4 mmol) in CH Cl (50 mL) with subsequent stirring for 2 h]. The reaction mixture was heated to room
4
2
2
temperature, stirred for 3 h, cooled to 10°C, and treated with a solution of NaOH (2.34 g, 58.5 mmol) in water (50 mL). The
organic layer was separated. The aqueous layer was extracted with CH Cl (3 × 50 mL) washed successively with saturated
2
2
solutions of NH Cl and water, dried over Na SO , and evaporated to produce a mixture (1.15 g) consisting according to GC
4
2
4
of 3 (50%) and 10 (50%), which was separated chromatographically over SiO (PE:ethylacetate = 7:3).
2
13
The IR spectra, PMR spectra, and C NMR spectra of 3 prepared by methods a-c were practically identical to those
described above.
3R,7-Dimethyl-6-oxooctyl Ester of 3R,7-Dimethyl-6-oxooctanoic Acid (10), R 0.57 (PE:ethylacetate = 7:3),
f
20
-1
[α]
+13.6° (c 1.73, CHCl ). IR spectrum (KBr, ν, cm ): 1735, 1705 (C=O), 1030 (C–O–C).
D
3
3
PMR spectrum (CDCl , δ, ppm, J/Hz): 0.98 (6H, d, J = 6.7, CH C-3, CH C-3′), 1.07 (12H, d, J = 7.0, CH C-7,
3
3
3
3
CH C-7′, H-8, H-8′), 1.33-1.49 (3H, m, H-2′, H-4, H-4′), 1.51-1.68 (3H, m, H-2′, H-4, H-4′), 1.90-2.25 (2H, m, H-3, H-3′), 2.09
3
2
3
2
3
(1H, dd, J = 15.2, J = 7.4, H-2), 2.25 (1H, dd, J = 15.2, J = 6.0, H-2), 2.40-2.48 (4H, m, H-5, H-5′), 2.60-2.75 (2H, m, H-7,
H-7′), 4.03 (2H, t, J = 6.6, H-1′).
13
C NMR spectrum (CDCl , δ, ppm): 18.10 (q, CH C-7, C-8, CH C-7′, C-8′), 18.95 (q, CH C-3), 19.29 (q, CH C-3′),
3
3
3
3
3
29.27 (d, C-3′), 29.74 (d, C-3), 30.02 (t, C-4), 30.26 (t, C-4′), 35.08 (t, C-7), 37.53 (t, C-2′, C-5′), 40.53 (d, C-7, C-7′), 42.25
(t, C-2), 62.27 (t, C-1′), 172.65 (s, C-1), 214.13 (s, C-6′), 214.42 (s, C-6).
20
3R,7-Dimethyl-6-oxooctanoic Acid (11), R 0.25 (PE:ethylacetate = 7:3), [α]
+9.90° (c 0.25, CHCl ). IRspectrum
f
D
3
-1
(KBr, ν, cm ): 1705, 1725 (C=O).
3
3
PMR spectrum (CDCl , δ, ppm, J/Hz): 0.98 (3H, d, J = 6.7, CH C-3), 1.10 (6H, d, J = 7.0, CH C-7, H-8), 1.49 (1H,
3
3
3
3
2
3
3
2
3
dtd, J = 14.8, J = 5.7, J = 3.9, H-4), 1.67 (1H, dtd, J = 14.8, J = 7.7, J = 8.7, H-4), 1.90-2.20 (1H, m, H-3), 2.18 (1H, dd,
J = 15.1, J = 7.9, H-2), 2.34 (1H, dd, J = 15.1, J = 6.0, H-2), 2.43-2.52 (2H, m, H-5), 2.61 (1H, septet, J = 7.0, H-7), 8.9
(1H, br.s, OH).
2
3
2
3
3
43